EN
HI
Summary
As of 8 Nov, 2026, Cohance Lifesciences stock price is ₹442. During the trading session, the stock has moved between an intraday low of ₹415.00 and an intraday high of ₹444.80. Over the last 52 weeks, Cohance Lifesciences has traded between ₹266.70 and ₹715.00.
The stock has recorded a trading volume of 3,47,006 shares,. Its Average Traded Price (ATP) is ₹437.04, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹442.00.
Cohance Lifesciences has an upper circuit limit of ₹520.25 and a lower circuit limit of ₹346.85. The total value traded stands at ₹15.17 CR, and the delivery percentage for the day is 36.56%.
The stock is currently traded with a market lot size of 1. Cohance Lifesciences also offers a dividend yield of 0%.
Cohance Lifesciences Share Price Chart
Cohance Lifesciences Share Key Metrics
Volume
3.47 L
Market Cap
16910.80 CR
LTQ@LTP
2@442.00
ATP
437.04
Var Margin
22.04 %
Circuit Range
346.85-520.25
Delivery %
36.56 %
Value
15.17 CR
ASM/GSM
No
Market Lot
1
Cohance Lifesciences Fundamentals
P/E Ratio
350.17
P/B Ratio
4.31
Div. Yield
0
Sector P/E
40.24
Sector P/B
3.67
Sec. Div. Yield
0.52
Cohance Lifesciences Resistance and Support
Pivot 434.07
Resistance
First Resistance
443.14
Second Resistance
452.72
Third Resistance
461.79
Support
First Support
424.49
Second Support
415.42
Third Support
405.84
Cohance Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Sun Nov 08 2026 | 415 | 442 | 1.95% | 444.8 | 415 |
| Fri Nov 06 2026 | 440 | 433.54 | -3.44% | 443.64 | 425 |
| Thu Nov 05 2026 | 453.79 | 449 | -0.32% | 458.2 | 446.95 |
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-06 | Quarterly Results |
| 2026-08-05 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences Ltd - 543064 - Update On USFDA Inspection For Company'S Pashamylaram Manufacturing Facility
Cohance Lifesciences announced that the USFDA has issued an Establishment Inspection Report (EIR) for its manufacturing facility in Pashamylaram, Hyderabad. The inspection outcome has been classified as Voluntary Action Indicated (VAI), marking the conclusion of the inspection.
Nov 07 2026 11:11:27
Cohance Lifesciences Ltd - 543064 - General Announcement
Cohance Lifesciences has been directed by the Telangana State Pollution Control Board to suspend manufacturing at its Suryapet site immediately. The order follows an industrial accident that resulted in an employee's death and alleged non-compliance with safety measures.
Nov 06 2026 08:22:23
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Umang Vohra | Chairman |
| Himanshu Agarwal | Whole Time Director |
Cohance Lifesciences Similar Stocks
Caplin Point Laboratories Ltd.
2457.20
74.70 (3.14%)
Onesource Specialty Pharma Ltd.
1632.60
32.80 (2.05%)
Shilpa Medicare Ltd.
953.65
11.30 (1.20%)
Pfizer Ltd.
3903.80
47.80 (1.24%)
Alembic Pharmaceuticals Ltd.
1010.00
44.85 (4.65%)
Eris Lifesciences Ltd.
1252.70
18.60 (1.51%)
Dr. Agarwal's Health Care Ltd.
514.60
-1.75 (0.34%)
Poly Medicure Ltd.
1598.40
-13.90 (0.86%)
Molbio Diagnostics Ltd.
1360.20
20.90 (1.56%)
Natco Pharma Ltd.
805.05
-1.95 (0.24%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 442 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 350.17. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 4.31. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 40.24 & 3.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 16910.80 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 715.00 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in COHANCE
